IMMUCELL CORP /DE/

10-K Item 1C cybersecurity disclosure describing the registrant's cybersecurity risk-management program, use of outside consultants, and Board-level oversight. The filer affirmatively states that, as of March 30, 2026, it is not aware of any cybersecurity threats that have materially affected, or are reasonably likely to materially affect, its business strategy, results of operations, or financial condition. No specific cybersecurity incident is disclosed.